Adriana Camargo Carvalho

ORCID: 0000-0002-2914-0010
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Economic and Financial Impacts of Cancer
  • Colorectal Cancer Treatments and Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Health Literacy and Information Accessibility
  • Health Systems, Economic Evaluations, Quality of Life
  • Anesthesia and Neurotoxicity Research
  • Technology Use by Older Adults
  • Chronic Lymphocytic Leukemia Research
  • Mobile Health and mHealth Applications
  • Poisoning and overdose treatments
  • Electrolyte and hormonal disorders
  • Nail Diseases and Treatments
  • Public Health in Brazil
  • Cardiac Arrest and Resuscitation
  • Enhanced Recovery After Surgery
  • Pancreatic and Hepatic Oncology Research
  • Chemotherapy-related skin toxicity
  • Pharmacology and Obesity Treatment
  • Sympathectomy and Hyperhidrosis Treatments
  • Gastric Cancer Management and Outcomes

Universidade Estadual de Campinas (UNICAMP)
2011-2022

University Medical Center Utrecht
2022

Utrecht University
2022

Centro de Estudos em Psicologia da Saúde
2016

Digital inclusion and literacy facilitate access to health information can contribute self-care behaviors informed decision-making. However, digital is not an innate skill, but rather requires knowledge acquisition.The present study aimed develop, conduct, measure the impact, on literacy, of a program at community dwellers.The targeted recruitment people aged 55 older that owned mobile devices with internet connection in 3 cities northern Portugal (Paredes de Coura, Guimarães, Barcelos). The...

10.2196/41873 article EN cc-by JMIR Formative Research 2022-10-24

Cetuximab and panitumumab are monoclonal antibodies targeting the epidermal growth factor receptor. Both drugs active against RAS wild type metastatic colorectal cancer after chemotherapy failure, with similar efficacy toxicity profiles. However, their cost limited survival benefits may compromise incorporation in Brazilian public healthcare system, Unified Heath System (Sistema Único de Saúde) (SUS).A cost-effectiveness analysis was conducted using a Markov model from Public health...

10.1371/journal.pone.0175409 article EN cc-by PLoS ONE 2017-04-12

Blister formation and eccrine sweat gland necrosis is a cutaneous manifestation associated with states of impaired consciousness, most frequently reported after overdoses central nervous system depressants, particularly phenobarbital. The case 45-year-old woman who developed "coma blisters" at six distinct anatomic sites confirmed (laboratory) phenobarbital poisoning, other depressants (clonazepam, promethazine, oxcarbazepine quetiapine), presented. A biopsy from the left thumb blister taken...

10.1590/s0365-05962012000400016 article EN cc-by Anais Brasileiros de Dermatologia 2012-08-01

To evaluate plasmatic arginine vasopressin (AVP) levels in patients undergoing scheduled conventional abdominal aortic aneurysm (AAA) repair.Plasmatic AVP concentrations were measured by radioimmunoassay 22 non-consecutive adult infra-renal AAA repair. They under combined general and epidural anesthesia at the following time frames: 1--pre-operative (T0); 2--2h (T1) 6h (T2) after surgical procedure; 3--in morning first (T3), second (T4) third (T5) post-operative days. Some clinical...

10.5935/1678-9741.20110015 article EN cc-by Brazilian Journal of Cardiovascular Surgery 2011-01-01

e17525 Background: Trastuzumab is a recombinant humanized monoclonal antibody that selectively targets the extra-cellular domain of HER2 receptor, and has significantly improved outcomes for women with both early metastatic HER2-positive breast cancer. In 2013, Brazilian National Sanitary Vigilance Agency (ANVISA) approved trastuzumab only adjuvant treatment in patients The objective this assessment to critically review efficacy combination first-line chemotherapy HER-positive cancer,...

10.1200/jco.2014.32.15_suppl.e17525 article EN Journal of Clinical Oncology 2014-05-20

680 Background: The first-line treatment with tyrosine kinase inhibitors results in significant clinical benefits for patients metastatic renal cell carcinoma (mRCC). However, Brazilian public health system Interferon still remains as standard treatment. In an innovative way, the Society of Clinical Oncology made a price negotiation directly pharmaceutical company, aiming to propose formal request incorporation these technologies National Committee Health Technology Incorporation (CONITEC)....

10.1200/jco.2018.36.6_suppl.680 article EN Journal of Clinical Oncology 2018-02-20

Abstract Background : Chronic lymphocytic leukemia is the most common type of in Western world. During past decade, treatment options have expanded, along with an expressive rise costs. In Brazil, overall costs cancer are rising, mainly due to judicialization lawsuits. The efficacy and safety rituximab combined fludarabine cyclophosphamide (R-FC) for chronic has been demonstrated by CLL8 trial, which was conducted previously untreated patients, positioning immunochemotherapy regimen as a...

10.21203/rs.3.rs-1475543/v1 preprint EN cc-by Research Square (Research Square) 2022-03-23

<sec> <title>BACKGROUND</title> Digital inclusion and literacy facilitates access to health information can contribute self-care behaviours informed decision-making. However, digital is not an innate skill, rather it requires knowledge acquisition. </sec> <title>OBJECTIVE</title> The present study aimed develop, conduct, measure the impact, on literacy, of a program (termed “OITO Project”) at community-dwellers aged 55 years old above. <title>METHODS</title> intervention was organized as...

10.2196/preprints.41873 preprint EN 2022-08-12

Abstract BACKGROUND Chronic Lymphocytic leukemia is the most common in western world. In last decade, treatment options expanded with an expressive rise costs. Brazil overall cancer costs are rising mainly due to judicialization law suits. The efficacy and safety of associating rituximab fludarabine cyclophosphamide (R-FC) for chronic lymphocytic has been demonstrated by CLL8 trial, which was conducted previously untreated patients positioning immunochemotherapy regimen as standard choice...

10.21203/rs.3.rs-137750/v1 preprint EN cc-by Research Square (Research Square) 2021-01-05
Coming Soon ...